Dosage Forms

Articles

Experts attending the European Psychiatry Association Congress in Vienna say that Adasuve has made an impact in the treatment of agitation in patients suffering from schizophrenia or biopolar I disorder.

Innovative Inhaled Antipsychotic Formulation Adasuve Provides Quick and Effective Treatment

CVS Health signed a definitive agreement to acquire Omnicare for $12.7 billion to expand its reach to assisted living and long-term care facilities.

CVS Inks Deal to Acquire Omnicare for $12.7 Billion

Adeline Siew is editor for Pharmaceutical Technology Europe. She is also science editor for Pharmaceutical Technology.

Advances in transdermal drug delivery, particularly with microneedles, are enabling a wider range of drugs to be delivered through the skin.

Transdermal Drug Delivery Gains Traction

Dicerna Pharmaceuticals announces that FDA granted its primary hyperoxaluria type 1 (PH1) treatment Orphan Drug designation.

Dicerna Receives Orphan Drug Designation for PH1 Treatment

Recipharm makes a strategic investment in Synthonics and partners in development of novel compounds.

Recipharm Invests in Sythonics

Randi Hernandez was science editor at Pharmaceutical Technology from September 2014 to May 2017.

Drug spending rose last year at the highest rate since 2003, driven by specialty medicines, according to a report from pharmacy benefit manager Express Scripts.

Drug Spending Highest Since 2003, Says Report

Sanofi launched a rapidly absorbed, short-acting inhalable insulin in the US to help control type 1 and type 2 diabetes.

First Inhalable Insulin Comes to the US

The 2016 White House Budget proposes a change to the data exclusivity period for biologics and the authority to influence drug pricing.

Obama Seeks Drug Pricing Authority, Shortened Data Exclusivity Period for Biologics

Entrectinib has received FDA’s orphan drug and rare pediatric disease designations for the treatment of neuroblastoma.

Ignyta’s Neuroblastoma Treatment Receives Orphan Drug Designation

Lung Therapeutics announced that it received Orphan Drug Designation for LTI-01, an injectable designed for the treatment of loculated pleural effusion.

Specialty Dosage Drugs